Anchor Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.37M Sell
8,086
-1,069
-12% -$351K 0.2% 125
2025
Q4
$3.21M Buy
9,155
+1,267
+16% +$428K 0.26% 102
2025
Q3
$2.55M Buy
7,888
+1,010
+15% +$314K 0.21% 120
2025
Q2
$2.68M Buy
6,878
+388
+6% +$156K 0.23% 113
2025
Q1
$2.82M Sell
6,490
-911
-12% -$366K 0.26% 98
2024
Q4
$2.73M Buy
7,401
+1,303
+21% +$545K 0.25% 104
2024
Q3
$3.17M Buy
6,098
+1,135
+23% +$606K 0.3% 89
2024
Q2
$2.69M Buy
4,963
+204
+4% +$108K 0.28% 94
2024
Q1
$2.47M Buy
4,759
+208
+5% +$103K 0.26% 104
2023
Q4
$2.15M Buy
4,551
+1,142
+33% +$528K 0.25% 107
2023
Q3
$1.48M Sell
3,409
-540
-14% -$245K 0.19% 123
2023
Q2
$1.75M Buy
3,949
+166
+4% +$76.6K 0.22% 117
2023
Q1
$1.74M Buy
3,783
+280
+8% +$133K 0.24% 113
2022
Q4
$1.8M Buy
3,503
+68
+2% +$34.5K 0.26% 112
2022
Q3
$1.56M Buy
3,435
+172
+5% +$82.3K 0.24% 110
2022
Q2
$1.57M Buy
3,263
+61
+2% +$30.2K 0.23% 114
2022
Q1
$1.57M Buy
3,202
+224
+8% +$102K 0.2% 122
2021
Q4
$1.38M Buy
2,978
+156
+6% +$65.6K 0.17% 130
2021
Q3
$1.05M Buy
2,822
+51
+2% +$19.4K 0.15% 155
2021
Q2
$1.06M Sell
2,771
-2
-0.1% -$764 0.15% 152
2021
Q1
$995K Buy
2,773
+1,195
+76% +$384K 0.15% 146
2020
Q4
$507K Buy
1,578
+113
+8% +$34.7K 0.09% 187
2020
Q3
$393K Buy
1,465
+72
+5% +$19.4K 0.08% 187
2020
Q2
$366K Sell
1,393
-81
-5% -$21.6K 0.08% 186
2020
Q1
$335K Buy
1,474
+439
+42% +$120K 0.09% 187
2019
Q4
$313K Sell
1,035
-29
-3% -$7.98K 0.07% 221
2019
Q3
$255K Buy
1,064
+63
+6% +$17.3K 0.06% 250
2019
Q2
$282K Buy
1,001
+176
+21% +$48.1K 0.07% 232
2019
Q1
$237K Buy
825
+465
+129% +$134K 0.06% 258
2018
Q4
$94.5K Hold
360
0.03% 351
2018
Q3
$98.7K Hold
360
0.02% 379
2018
Q2
$85.7K Hold
360
0.02% 407
2018
Q1
$79.1K Hold
360
0.02% 421
2017
Q4
$81K Hold
360
0.02% 403
2017
Q3
$68.4K Hold
360
0.02% 414
2017
Q2
$67.7K Hold
360
0.02% 373
2017
Q1
$59.5K Hold
360
0.02% 377
2016
Q4
$51.8K Hold
360
0.02% 379
2016
Q3
$45.1K Buy
360
+60
+20% +$7.75K 0.02% 363
2016
Q2
$39.4K Hold
300
0.02% 376
2016
Q1
$41.7K Buy
+300
New +$40.1K 0.02% 360

Other funds holding ELV

Anchor Investment Management's ELV Position: Q1 2026 in Review

Anchor Investment Management reduced its Elevance Health (ELV) stake by 12% in Q1 2026, selling an estimated $351K and leaving 8,086 shares worth $2.37M. The position accounts for 0.2% of the portfolio, ranked #125.

Anchor Investment Management first reported a position in ELV in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.21M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Anchor Investment Management held 8,086 shares of Elevance Health worth $2.37M as of Q1 2026.
  • Anchor Investment Management sold 1,069 Elevance Health shares in Q1 2026, an estimated $351K.
  • Elevance Health made up 0.2% of Anchor Investment Management's portfolio in Q1 2026, its #125 holding.
  • Anchor Investment Management first reported a position in Elevance Health in Q1 2016 and has held it in 41 quarters since.
  • Anchor Investment Management's Elevance Health position peaked at $3.21M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.